Startups
Nuvectra® is a neuromodulation company committed to helping physicians improve the lives of people with chronic conditions through our medical devices.
At Nuvectra, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers.
The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease.
At Nuvectra, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers.
The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease.
Overview
Location
United States, Texas, Plano
Employees
51-200
Phone
(844) 727-7897
Founded date
2016
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 27, 2016 | Aleva Neurotherapeutics Raises USD 18 Million in Series C Financing Round |
Reviews 0
FAQ about Nuvectra
When was Nuvectra founded?
Nuvectra was founded in 2016.
What has the press written about Nuvectra?
Parsers VC has collected 2 articles mentioning Nuvectra, among them “Aleva Neurotherapeutics Raises USD 18 Million in Series C Financing Round” (May 27, 2016).
Is Nuvectra still active?
Yes, Nuvectra is active; its latest activity on Parsers VC dates from May 7, 2024.